The Vaccine & Gene Therapy Institute of Florida (VGTI Florida®) is delighted to announce the election of Mr. Kevin Kelly to their Board of Directors. Mr. Kelly brings extensive experience and perspective in high-level multinational business and finance management to the Institute.
Mr. Kelly spent 35 years with the Volkswagen Group of America, most recently as the President and CEO of Volkswagen Credit, Inc. from 2000 to 2011, as well as Executive VP of Volkswagen of America, Inc. from 2004 to 2011.
“Kevin is a wonderful addition to the Institute’s Board of Directors,” said Dr. Richard Jove, Director of VGTI Florida. “Our Institute is made up of such a dynamic group of scientists and administrators, and our expanding Board of Directors definitely reflects this.”